Evidence map›Paper›PMID 23748117›Full record

Trial reportPain2013

Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.

Stephen Bruehl, John W Burns, Rajnish Gupta, Asokumar Buvanendran, Melissa Chont, Ellen Kinner, Erik Schuster, Steven Passik, Christopher R France

3 registry-linked trialsOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Pain, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02469077 nacompletednot on this mapstarted 2015, after this paper: background citation

Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function

TypeinterventionalSponsorVanderbilt University Medical CenterRan2015 to 2019Enrolled117ConditionsChronic PainArms6 week aerobic exercise intervention, Placebo, Morphine, naloxone
NCT04744883 early_phase1active not recruitingnot on this mapstarted 2020, after this paper: background citation

Evaluating Specific and Non-Specific Mechanisms in Two Distinct Complementary/Integrative Interventions for Chronic Pain

TypeinterventionalSponsorRush University Medical CenterRan2020 to 2026Enrolled140ConditionsChronic Low-back PainArmsSpinal Manipulation Therapy (SMT), Naloxone, Placebo, Mindfulness Based Stress Reduction Therapy (MT)
NCT05142267 narecruitingnot on this mapstarted 2022, after this paper: background citation

Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms

TypeinterventionalSponsorVanderbilt University Medical CenterRan2022 to 2026Enrolled120ConditionsOpioid Use Disorder, Back Pain, StressArmsPlacebo, Oxycodone, Naloxone
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Psychophysics of Pain: A Methodological Introduction.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Is Resolution of Chronic Pain Associated With Changes in Blood Pressure-related Hypoalgesia?Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2018
    Article
  18. Article
  19. Expectancy Effects on Conditioned Pain Modulation Are Not Influenced by Naloxone or Morphine.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Stephen BruehlDepartment of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN, USA Department of Behavioral Science, Rush University, Chicago, IL, USA Department of Anesthesiology, Rush University, Chicago, IL, USA Department of Psychology, Ohio University, Athens, OH, USA.
John W Burns
Rajnish Gupta
Asokumar Buvanendran
Melissa Chont
Ellen Kinner
Erik Schuster
Steven Passik
Christopher R France
Rush University · USVanderbilt University · USOhio University · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Predictors of Opioid Analgesic Responses and Common Endogenous Opioid MechanismsR01DA031726 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRUEHL, STEPHEN, BURNS, JOHN W. · 2011 to 2015
$2.7M
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1TR000445NIDA NIH HHS R01 DA031726NIDA NIH HHS R01-DA031726
6 · The paper itself

Abstract

Predictors of responsiveness to opioid analgesic medications are not well understood. This study tested whether individual differences in endogenous opioid (EO) function are associated with analgesic responsiveness to morphine. In randomized, counterbalanced order over 3 sessions, 45 chronic low back pain participants and 31 healthy controls received an opioid antagonist (8 mg naloxone), morphine (0.08 mg/kg), or placebo. Participants then engaged in 2 laboratory-evoked pain tasks (ischemic and thermal). Outcomes included pain threshold, pain tolerance, and pain ratings. Indexes of EO function and morphine analgesic responsiveness were derived for each measure as the difference in pain responses between the placebo condition and naloxone or morphine condition, respectively. For all 7 pain measures across the 2 laboratory pain tasks, greater EO function was associated with significantly lower morphine analgesic responsiveness (P<0.001-P=0.02). Morphine reduced pain responses of low EO individuals to levels similar to those of high EO individuals receiving placebo. Higher placebo condition-evoked pain sensitivity was associated with significantly greater morphine analgesic responsiveness for 5 of 7 pain measures (P<0.001-P=0.02). These latter associations were significantly mediated by EO function for 4 of these 5 pain outcomes (all P values<0.05). In the laboratory-evoked pain context, opioid analgesic medications may supplement inadequate EO analgesia, with little incremental benefit in those with preexisting high EO function. Implications for personalized medicine are discussed.

Indexed as

AdultAnalgesics, OpioidCross-Sectional StudiesDouble-Blind MethodFemaleHumansHyperalgesiaMaleMiddle AgedMorphineNaloxoneNarcotic AntagonistsPainPain MeasurementPain ThresholdPhysical StimulationAnalgesics, OpioidMorphineNaloxoneNarcotic AntagonistsChronic painEndogenous opioidsMediationOpioid analgesicPainPersonalized medicine

Identifiers

PMID23748117
PMCPMC4069065
OpenAlexW2006034999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.